SCREENING FOR OVARIAN-CANCER - THE PRELIMINARY EXPERIENCE OF A FAMILIAL OVARIAN-CANCER CENTER

被引:55
|
作者
MUTO, MG
CRAMER, DW
BROWN, DL
WELCH, WR
HARLOW, BL
XU, HJ
BRUCKS, JP
TSAO, SW
BERKOWITZ, RS
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DIV GYNECOL ONCOL,BOSTON,MA 02115
[2] HARVARD UNIV,BRIGHAM & WOMENS HOSP,CTR OBSTET GYNECOL EPIDEMIOL,BOSTON,MA 02115
[3] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DEPT RADIOL,BOSTON,MA 02115
[4] HARVARD UNIV,BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115
[5] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1006/gyno.1993.1239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Women with a family history of ovarian cancer represent a high-risk group for the development of epithelial ovarian cancer. From July 1990 through December 1992, 386 women with a first-degree or multiple second-degree relatives with confirmed ovarian cancer were enrolled in a study to assess the utility of screening with transvaginal sonography, color flow doppler, and CA125. The mean age of the group was 41: 85% were premenopausal and 89/384 (23%) had 2 or more relatives with ovarian cancer. An initial ultrasound examination was abnormal in 89/384 (23%), 89% of whom were premenopausal. A persistent ovarian mass was detected in 15 patients and all were surgically proven to be benign. Mean CA125 levels were significantly higher and more variable in pre- vs postmenopausal women. CA125 was ≥35 U/ml in 42/386 (11%) (36-232 U/ml). All but one of these women were premenopausal and 50% subsequently normalized. Two patients who were surgically explored for a rising CA125 had normal ovaries. An additional 19 patients have undergone prophylactic oophorectomy with no consistent histopathologic abnormality identified. These data demonstrate the difficulty inherent in screening a predominantly premenopausal population and do not clearly establish the efficacy of these modalities in the early detection of ovarian cancer. © 1993 Academic Press, Inc.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 50 条
  • [1] ULTRASOUND SCREENING FOR FAMILIAL OVARIAN-CANCER
    BOURNE, TH
    WHITEHEAD, MI
    CAMPBELL, S
    ROYSTON, P
    BHAN, VJ
    COLLINS, WP
    [J]. GYNECOLOGIC ONCOLOGY, 1991, 43 (02) : 92 - 97
  • [2] EXPERIENCE OF FAMILIAL OVARIAN-CANCER IN ABERDEEN
    GREGORY, H
    SEMPER, J
    DESILVA, D
    HAITES, NE
    [J]. JOURNAL OF MEDICAL GENETICS, 1995, 32 (02) : 145 - 145
  • [3] FAMILIAL OVARIAN-CANCER
    NGAN, HYS
    SHEPHERD, JH
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 1994, 52 (2-3) : 99 - 102
  • [4] FAMILIAL OVARIAN-CANCER
    BULLER, RE
    ANDERSON, B
    CONNOR, JP
    ROBINSON, R
    [J]. GYNECOLOGIC ONCOLOGY, 1993, 51 (02) : 160 - 166
  • [5] ON FAMILIAL OVARIAN-CANCER
    CHUDINA, AP
    AKULENKO, LV
    PICHUGINA, MN
    POGOSYANZ, EE
    [J]. VOPROSY ONKOLOGII, 1980, 26 (12) : 84 - 90
  • [6] FAMILIAL OVARIAN-CANCER
    VANEIJKEREN, MA
    DEGRAAFF, J
    VANETTEN, FHPM
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1992, 47 (03): : 263 - 266
  • [7] FAMILIAL OVARIAN-CANCER
    SCHWARTZ, PE
    [J]. CANCER, 1995, 75 (10) : 2637 - 2637
  • [8] FAMILIAL OVARIAN-CANCER
    LURAIN, JR
    PIVER, MS
    [J]. GYNECOLOGIC ONCOLOGY, 1979, 8 (02) : 185 - 192
  • [9] FAMILIAL OVARIAN-CANCER
    LURAIN, JR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (23): : 3343 - 3343
  • [10] OVARIAN-CANCER SCREENING
    GOSINK, BB
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (05) : 1591 - 1592